Senior Director, Pipeline Market Access Strategy - Oncology

AbbVie•Mettawa, IL

8h•$206,500 - $393,000

About The Position

The Senior Director, Pipeline Market Access Strategy (PMAX) leads the end-to-end global market access strategy for pipeline assets within an assigned Business Unit. The role embeds pricing and access considerations from early development through Phase 3, shaping clinical trial design, evidence generation, and target product profiles to support future commercialization. It develops distinct but aligned US and international strategies to optimize global launch success amid changing pharmaceutical pricing and reimbursement environments. The Senior Director leads experts across US and International Pipeline Strategy and defines the team's objectives and vision. The role partners with inline access teams and with R&D, Regulatory, HEOR, Global Commercial Development, Business Development, Government Affairs, and other functions to create integrated access strategies that support long-term commercial and patient-access outcomes. It also represents pipeline access at senior governance forums, contributes access perspectives to business development and asset evaluation, and guides pipeline-to-launch planning and readiness.

Requirements

Advanced degree (MBA, MPH, PhD, PharmD, or equivalent) in business, health economics, public policy, life sciences, or a related field.
Bachelor's degree in a scientific, business, or public health discipline as a minimum baseline.
12–15 years of progressive senior-level experience in market access, pricing, reimbursement, HEOR, or a closely related pharmaceutical or biopharmaceutical function, with a substantial portion focused on pipeline and pre-launch strategy.
Demonstrated global market access expertise, including working knowledge of HTA processes, payer evidence requirements, pricing and reimbursement frameworks, and access decision-making across the US, EU5, Japan, and other key markets.
Experience shaping clinical development strategy from market access and outcomes evidence perspectives, including contribution to clinical trial design, endpoint selection, and Integrated Evidence Plan development with R&D teams.
Track record of leading and developing high-performing teams in a matrixed, multinational environment, managing direct reports and influencing cross-functional partners without direct authority.
Ability to communicate complex access strategy to executive audiences and influence enterprise-level pipeline investment decisions.
Deep expertise in at least one therapeutic area.

Nice To Haves

Formal training or demonstrated expertise in health technology assessment, health economics, outcomes research, or pharmaceutical development.
Experience supporting Business Development activities, including asset due diligence, licensing evaluations, and access-based valuation assessments.
Experience across multiple therapeutic areas, such as Oncology, Immunology, and Neuroscience.

Responsibilities

Own the end-to-end integrated market access strategy for pre-launch and development-stage assets in the assigned Business Unit, including evidence needs, policy considerations, pricing potential, and commercial considerations through regulatory submission.
Represent pipeline market access strategy at Business Unit governance forums and senior leadership reviews, communicating access risks, opportunities, and strategic direction.
Provide market access input to pipeline Business Development opportunities and support asset evaluation.
Prioritize pipeline portfolio resources and strategic attention according to access complexity and business impact.
Create and optimize launch strategies that account for IRA, MFN, US channel dynamics, indication sequencing, and geographic considerations.
Define and deliver an Access Roadmap for each pipeline asset by development phase, anticipated launch timing, and global evidence deliverables.
Partner with R&D and Regulatory to incorporate access-relevant endpoints, comparators, and trial design elements into development programs from Phase I/II onward, including collaboration with affiliates.
Define and champion market-access-oriented Target Product Profiles, translating payer value requirements into clinical and evidence-generation guidance.
Generate and maintain global payer and HTA evidence requirements across major markets, including the US, EU5, Japan, and emerging markets.
Provide strategic leadership to the US Pipeline Strategy Lead and International Pipeline Strategy Lead, integrating their perspectives into Business Unit-level strategy.
Align US payer strategy, formulary positioning, and value communication with international HTA, pricing, and reimbursement approaches while allowing for local requirements.
Anticipate cross-market reference pricing, parallel trade, and HTA precedent effects and incorporate them into pipeline strategy.
Develop and execute a pipeline-to-launch transition framework with US and International Pipeline Strategy Leads, preparing access strategies, payer evidence packages, and reimbursement submissions ahead of regulatory approval.
Collaborate with US and international commercial, medical, and market access teams on knowledge transfer and handoff at regulatory approval, including payer communications, launch sequencing, and country-level readiness assessments.
Lead cross-functional launch readiness reviews to identify and resolve evidence, pricing approval, and formulary positioning gaps before approval.
Ensure affiliate and in-country access teams receive globally aligned value messages, health economic tools, and reimbursement dossiers ahead of launch.
Provide strategic direction and partnership to HEOR, R&D, Regulatory, Global Commercial Development, Global Marketing, Government Affairs, and Business Development.
Lead Integrated Evidence Plan development with HEOR, aligning real-world evidence, health economic modeling, and outcomes research with anticipated payer and HTA requirements.
Partner with Government Affairs to anticipate and shape policy and reimbursement developments and incorporate policy risk and opportunity assessments into pipeline strategies.
Collaborate with Global Commercial Development and Global Marketing to align access strategies with brand positioning, indication sequencing, and long-range commercial forecasts.
Support Business Development with payer landscape assessments, reimbursement probability analyses, and access risk evaluations for in-licensing, partnership, and acquisition opportunities.
Establish and communicate access-based licensing priorities that account for payer evidence requirements, competitive access dynamics, and global pricing sustainability.
Serve as the access subject matter expert in due diligence, assessing payer readiness and evidence maturity of external pipeline assets.
Represent pipeline market access priorities at senior governance forums, portfolio review committees, and cross-Business Unit strategy sessions.
Build, develop, and retain a high-performing pipeline access team, including mentorship, career development, and performance management for direct and indirect reports across US and international functions.
Foster innovation, rigor, and affiliate-centricity by incorporating affiliate launch needs, in-country market dynamics, and local payer requirements into global strategy.